Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol

Journal of Neural Transmission

Volumn 107, Issue 8-9, 2000, Pages 1009-1019

  Antkiewicz Michaluk, L ^a   Michaluk, J ^a   Romanska I ^a   Papla, I ^a   Vetulani, J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1,2,3,4 tetrahydroisoquinoline; Anti dopaminergic activity; Apomorphine; Dopamine metabolism; Haloperidol; Salsolinol

Indexed keywords

3 O METHYLDOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; APOMORPHINE; DOPAMINE; HALOPERIDOL; HOMOVANILLIC ACID; SALSOLINOL; TETRAHYDROISOQUINOLINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG BINDING SITE; DRUG EFFECT; LOCOMOTION; MALE; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMAL; ANTIPARKINSON AGENTS; APOMORPHINE; BINDING, COMPETITIVE; BRAIN CHEMISTRY; CATALEPSY; DOPAMINE; DOPAMINE ANTAGONISTS; HALOPERIDOL; HOMOVANILLIC ACID; ISOQUINOLINES; MALE; MOTOR ACTIVITY; NEUROTOXINS; PARKINSON DISEASE; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T; TRITIUM;

EID: 0033787623     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070049     Document Type: Article

References (31)

1. Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: Advantage of a new high-performance liquid chromatography methodology
2. The role of central dopamine system in the mechanism of action of tetrahydroisoquinolines. XIII International Congress of Pharmacology, Munchen
3. Neurochemical changes induced by acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline and salsolinol in dopaminergic structures of rat brain
4. Stimulatory and inhibitory action of clonidine on the locomotor activity in the rat
5. Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat
6. The clinical syndrome of striatal dopamine deficiency: Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
7. Assay for the (R)- and (S)-enantiomers of salsolinols in biological samples and foods with ion-pair high-performance liquid chromatography using beta-cyclodextrin as a chiral mobile phase additive
8. Influence of amphetamine and scopolamine on the catalepsy induced by diencephalic lesions in rats
9. Salsolinol and dopamine in alcoholic beverages
10. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of disease in man
11. Dopaminergic antagonists: Effects of 1,2,3,4-tetrahydroisoquinoline and its N-methyl and N-propyl homologs on apomorphine and L-dopa induced behavioral effects in rodents
12. Effect of acute and chronic administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on muscle tone, metabolism of dopamine in the striatum and TH-immunocytochemistry in the substantia nigra
13. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain
14. Isoquinoline neurotoxins in the brain and Parkinson's disease
15. An endogenous substance of the brain, tetrahydroisoquinoline produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal region
16. Characterization of the in vivo action of (R)-salsolinol, an endogenous metabolite of alcohol, on serotonin and dopamine metabolism: A microdialysis study
17. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methylisoquinolinum ion by monoamine oxidase
18. A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tatrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinum ion
19. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins
20. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin
21. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: Biochemical, pathological and behavioral studies
22. Oxidation of N-methyl(R)salsolinol: Involvement to neurotoxicity and neuroprotection by endogenous catechol isoquinolines
23. Presence of tetrahydroisoquinoline, a parkinsonism-related compound, in foods
24. Rat brain salsolinol and blood-brain barrier
25. Identification of salsolinol as a major dopamine metabolite in the banana
26. Analysis of salsolinol and salsoline in biological samples using deuterium-labelled internal standards and gas chromatography - Mass spectrometry
27. Ratio of the R and S enantiomers of salsolinol in food and human urine
28. The neuroleptics. 3. Pharmacology. Introduction
29. The action of neuroleptics in rats with altered catecholamine metabolism, part I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol and thioridazine
30. Opposite effect of simple tetrahydroisoquinolines on amphetamine-and morphine-stimulated locomotor activity in mice
31. Thalamus as a relay station for catalepsy and rigidity